Selective estrogen receptor modulators: an update on recent clinical findings
about
FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection.Breast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexesEstrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines.In search of novel drug target sites on estrogen receptors using RNA aptamers.Non-feminizing estrogens: a novel neuroprotective therapy.Minireview: Estrogenic protection of beta-cell failure in metabolic diseases.New selective estrogen and androgen receptor modulatorsAlternative strategies for the treatment of classical congenital adrenal hyperplasia: pitfalls and promisesBazedoxifene: literature data and clinical evidenceAnti-breast cancer potential of SS5020, a novel benzopyran antiestrogenInflammatory osteoarthritis which was precipitated by Arimidex and resolved with tamoxifen.The assessment of non-feminizing estrogens for use in neuroprotection.Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management.Breast cancer medications and vision: effects of treatments for early-stage disease.Activation of G protein-coupled estrogen receptor induces endothelium-independent relaxation of coronary artery smooth muscle.Treatment of hypogonadotropic male hypogonadism: Case-based scenarios.Ospemifene and 4-hydroxyospemifene effectively prevent and treat breast cancer in the MTag.Tg transgenic mouse model.Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease.Neuroprotection with non-feminizing estrogen analogues: an overlooked possible therapeutic strategy.Antihyperlipidemic activity of chickpea sprouts supplementation in ovariectomy-induced dyslipidemia in ratsEvaluation of the psychometric properties of the BCPT Symptom Checklist with a sample of breast cancer patients before and after adjuvant therapy.The naphthol selective estrogen receptor modulator (SERM), LY2066948, is oxidized to an o-quinone analogous to the naphthol equine estrogen, equilenin.Selective estrogen receptor modulator (SERM) lasofoxifene forms reactive quinones similar to estradiolCell type- and estrogen receptor-subtype specific regulation of selective estrogen receptor modulator regulatory elementsProliferation of human mammary cancer cells exposed to 27-hydroxycholesterolPreparation of (99m)tc-clomiphene citrate as a novel agent for breast cancer imagingThe role of sevista in the management of dysfunctional uterine bleeding.The role of 17-beta estradiol in ischemic preconditioning protection of the heart.Fertility drugs and young-onset breast cancer: results from the Two Sister StudyRecovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid useCurrent and emerging therapies for the treatment of osteoporosisEffects of bavachin and its regulation of melanin synthesis in A375 cellsThe Effect of Selective Estrogen Receptor Modulators (SERMs) on the Tamoxifen Resistant Breast Cancer Cells.Prevention of osteoporosis-related fractures among postmenopausal women and older men.A study of efficacy of ormeloxifene in the pharmacological management of dysfunctional uterine bleeding.Osteoarthritis associated with estrogen deficiency.Neuroprotective actions of selective estrogen receptor modulators.Ormeloxifene - Looking beyond contraception.Selective estrogen receptor modulator BC-1 activates antioxidant signaling pathway in vitro via formation of reactive metabolitesExogenous testosterone: a preventable cause of male infertility.
P2860
Q24568225-3628992C-D5A6-442A-A063-74AEC9209485Q30409045-80DF4A73-D66A-444F-BAF2-B3F7BDA18FF1Q30478476-44586F7F-0B8F-4DDA-A974-457AD48F6D9AQ33632085-CCE188E4-C882-4B9A-9CE2-4FF293D8C141Q33693293-F6A3C45A-F636-4FD0-B982-56E056BF2E64Q33735534-34091453-4A61-4132-874A-AF22085B96CCQ33814078-9D27D2A8-8509-4C3E-92C9-B5BA3C2B52F3Q34002823-0BED2750-99DF-4E8E-8F61-18F8D7A5B1A1Q34213748-55CAE26D-DFFE-43D5-8F92-2C275D06F776Q34446978-0F8831E2-E43D-4147-8EB5-31B1D5969D33Q34536015-A6013EB4-5F5E-488F-91E1-6036E53F60E1Q34624609-47EEDEE2-8DF2-4C14-8799-9003F074E284Q34977063-E312A075-0D37-42F9-BC81-ACFCAABDB2BFQ35496778-F9B0BBD4-66CC-4A9E-A86C-BF7C10AD6738Q35543617-70F7BFCC-17B0-43F8-A2E5-141BE6E970A1Q35567872-981A45A2-7974-4605-AD04-BC822BD22202Q35634204-E791316B-292F-4B5B-BDBF-6329ED628AFAQ35636191-74D6B157-EC20-4629-B0CB-508F385A2419Q35657938-0CFA89E2-F9B6-46D0-866D-F09F6D7D860AQ35792233-7156CB8B-7661-4C71-AF5E-EF679F4DA381Q35846781-6A6D7961-8EFF-4FE2-968C-DB778384E323Q35869879-0220C69C-B892-463A-8DDF-6EA196CA395AQ36098828-EB9734C2-3811-406E-9838-CAC576EAD13CQ36167236-86A90C0B-2063-4CFB-97D4-FB05DA701194Q36244059-EEEAA743-9232-4206-BA1E-817504F0527EQ36417992-E6FA8C44-6E69-47BB-AF42-25451FE1D89AQ36622551-D90E3649-B314-418A-B464-CEE04D27A62BQ36772293-1953B0DB-1EC0-4564-B6C6-C7C30FE05E6DQ36790599-E5F74D42-71E8-4761-9E2B-93881D6D42B6Q36861538-3AB1A16E-3DAB-4C29-B745-30CACEA2AF3BQ36890431-326D6234-6292-4087-9A21-4E8F8D916A4BQ37000929-459FAFB4-D4E9-485B-B794-1D1AAE57FADFQ37326230-7653546A-BB63-4B34-AB4C-6B715A84FDC0Q37428448-739ED713-E9C2-4327-868F-9AC3C42C634FQ37429546-9852A827-3AE3-47E1-8C8F-D7681555F9B3Q37453959-693F316E-1C1A-43B9-8C27-5F2BFF55DBE9Q37479919-2053DD4F-747A-4535-A1D5-50FE69C47CB0Q37721921-F0912F3F-5BD7-4D06-B3F5-167D87837042Q37728299-FC6F7686-F3BD-4E9A-BE5E-D25408BC459EQ38712661-373460A4-6F6F-4428-818C-92DBB7D754D0
P2860
Selective estrogen receptor modulators: an update on recent clinical findings
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Selective estrogen receptor modulators: an update on recent clinical findings
@ast
Selective estrogen receptor modulators: an update on recent clinical findings
@en
Selective estrogen receptor modulators: an update on recent clinical findings
@nl
type
label
Selective estrogen receptor modulators: an update on recent clinical findings
@ast
Selective estrogen receptor modulators: an update on recent clinical findings
@en
Selective estrogen receptor modulators: an update on recent clinical findings
@nl
prefLabel
Selective estrogen receptor modulators: an update on recent clinical findings
@ast
Selective estrogen receptor modulators: an update on recent clinical findings
@en
Selective estrogen receptor modulators: an update on recent clinical findings
@nl
P2093
P1476
Selective estrogen receptor modulators: an update on recent clinical findings
@en
P2093
Mayme Wong
Michael W Draper
Robert B Jaffe
Venkatesh Krishnan
Wendy Shelly
P304
P356
10.1097/OGX.0B013E31816400D7
P407
P577
2008-03-01T00:00:00Z